Which data in the French registry for advanced chronic kidney disease for public health and patient care?

Database Dialysis End stage renal disease Epidemiology Registry Transplantation

Journal

Nephrologie & therapeutique
ISSN: 1872-9177
Titre abrégé: Nephrol Ther
Pays: France
ID NLM: 101248950

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 15 12 2021
revised: 07 01 2022
accepted: 07 01 2022
pubmed: 1 7 2022
medline: 27 7 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Chronic kidney disease is a chronic non-transmittable disease of increasing incidence. The advanced stages are complicated by high morbidity and mortality, and individual management is complex due to the various treatments required at stage 5 including renal replacement. For the healthcare system, this disease also requires complex care organization. National registers of patients on renal replacement therapy have been developed to improve patient management and care arrangements. The purpose of our review was to report on the history of the French registry, its organization, the information collected and its evolution in response to the stage 5 problem. We successively detail the information system with its inclusion criteria, architecture and tools developed, its security rules, mode and type of information collected, its quality controls and, finally, the glossary of data available within the registry.

Identifiants

pubmed: 35773143
pii: S1769-7255(22)00027-X
doi: 10.1016/j.nephro.2022.01.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

228-236

Informations de copyright

Copyright © 2022 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Aurélie Caillet (A)

Coordination régionale Basse-Normandie, CHU Côte de Nacre, Caen, France.

Franck Mazoué (F)

Coordination régionale PACA-Corse, AP-HM, Marseille, France.

Blandine Wurtz (B)

Coordination régionale Haute-Normandie, CHU de Rouen, Rouen, France.

Xabina Larre (X)

Coordination régionale Aquitaine, CHU de Bordeaux, Bordeaux, France.

Cécile Couchoud (C)

REIN Registry, Agence de la Biomédecine, 1, avenue du Stade de France, 93212 La Plaine-Saint-Denis, France.

Mathilde Lassalle (M)

REIN Registry, Agence de la Biomédecine, 1, avenue du Stade de France, 93212 La Plaine-Saint-Denis, France. Electronic address: mathilde.lassalle@biomedecine.fr.

Olivier Moranne (O)

Coordination régionale Languedoc-Roussillon, CHU de Nîmes, Nîmes, France; IDESP, Inserm, Université de Montpellier, Montpellier, France; Service de néphrologie-dialyse-aphérèse, Hôpital Universitaire de Nîmes, Université de Montpellier, Nîmes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH